Exports In 2022, Malaysia exported N/A in Lecithins and other phosphoaminolipids, making it the 31st largest exporter of Lecithins and other phosphoaminolipids in the world. At the same year, Lecithins and other phosphoaminolipids was the 1743rd most exported product in Malaysia. The main destination of Lecithins and other phosphoaminolipids exports from Malaysia are: Indonesia ($760k), Singapore ($540k), Philippines ($430k), Thailand ($328k), and Vietnam ($269k).
The fastest growing export markets for Lecithins and other phosphoaminolipids of Malaysia between 2021 and 2022 were Indonesia ($598k), Singapore ($437k), and Philippines ($325k).
Imports In 2022, Malaysia imported $16.4M in Lecithins and other phosphoaminolipids, becoming the 25th largest importer of Lecithins and other phosphoaminolipids in the world. At the same year, Lecithins and other phosphoaminolipids was the 1512th most imported product in Malaysia. Malaysia imports Lecithins and other phosphoaminolipids primarily from: Brazil ($4.02M), Chinese Taipei ($2.54M), Philippines ($2.04M), India ($1.89M), and China ($1.86M).
The fastest growing import markets in Lecithins and other phosphoaminolipids for Malaysia between 2021 and 2022 were Brazil ($2.77M), Chinese Taipei ($1.9M), and India ($1.16M).
COMPANIES In 2023, leading companies such as Halyard Health (1.33k), Coaster Fine Furniture (890), and Motorola (838) were at the forefront of shipping Lecithins and other phosphoaminolipids from Malaysia to the United States.